PATENT CLAIM ANALYSIS

Application Number: 15914830
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["435", "006100"]

Abstract:
Provided is an HPV E6, E7 mRNA assay, referenced herein as the “In Cell HPV Assay,” that is capable of sensitive and specific detection of normal cervical cells undergoing malignant transformation as well as abnormal cervical cells with pre-malignant or malignant lesions. The In Cell HPV Assay identifies HPV E6, E7 mRNA via in situ hybridization with oligonucleotides specific for HPV E6, E7 mRNA and quantitates the HPV E6, E7 mRNA via flow cytometry. The In Cell HPV Assay can be carried out in less than three hours directly from liquid-based cervical (“LBC”) cytology specimens. The In Cell HPV Assay provides an efficient and highly sensitive alternative to the Pap smear for determining abnormal cervical cytology.

Claim (Index 62):
The method according to  claim 56 , further comprising contacting the cells of the prepared cellular sample with an antibody.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 90.0
- Lexical Diversity: 1.80822
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12391634', '11050384', '12645202', '14149747', '13294101']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7902737447545566
- 35 USC 102 Novelty (BERT): 0.6053703143163797
- Combined Prediction Score: 0.771783401710739
- Mean Citation Score: 684.1419860000002
- Max Citation Score: 760.9752
- Similarity Product: 474.5176504932404

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test